|
|
|
|
Graduated in mathematics (University of Mohammed V, Morocco, 2014) and McS in Applied Mathematics (University of Mohammed V, Morocco, 2016). Phd in Applied Mathematics (University of Mohammed V, Morocco, 2021). Interested to the application of mathematical modeling to oncology, for therapy optimization, and specifically to CAR T cell immunotherapy treatment in B cell malignancies. |
-
CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models
Comm Nonlin Sci Numer Simul 94, 105570 (2021)
O. León-Triana, S. Sabir, G.F. Calvo, J. Belmonte-Beitia, S. Chulian, A. Martínez-Rubio, M. Rosa, A. Pérez-Martínez, M. Ramírez-Orellana, V.M. Pérez-García
- Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024) - Optimization of tisagenlecleucel treatments of lymphoma: An integrated human data-based approach using mathematical models
NOVARTIS (2023 - 2025)
|
Graduated in mathematics (University of Mohammed V, Morocco, 2014) and McS in Applied Mathematics (University of Mohammed V, Morocco, 2016). Phd in Applied Mathematics (University of Mohammed V, Morocco, 2021). Interested to the application of mathematical modeling to oncology, for therapy optimization, and specifically to CAR T cell immunotherapy treatment in B cell malignancies. |
- CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models
Comm Nonlin Sci Numer Simul 94, 105570 (2021)
O. León-Triana, S. Sabir, G.F. Calvo, J. Belmonte-Beitia, S. Chulian, A. Martínez-Rubio, M. Rosa, A. Pérez-Martínez, M. Ramírez-Orellana, V.M. Pérez-García
- Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024) - Optimization of tisagenlecleucel treatments of lymphoma: An integrated human data-based approach using mathematical models
NOVARTIS (2023 - 2025)